EFFECT OF NEUROMUSCULAR TRAINING ON SHOULDER FUNCTION

December 15, 2021 updated by: Aya Ahmed Elnour Noaman Nada, Cairo University

EFFECT OF NEUROMUSCULAR TRAINING ON SHOULDER FUNCTION IN PATIENTS WITH SHOULDER IMPINGEMENT SYNDROME: A DOUBLE BLINDED RANDOMIZED CONTROLLED TRIAL

This study will be conducted to compare the effect of neuromuscular training versus traditional strength training in terms of shoulder joint function, proprioception accuracy and isometric external and internal rotator muscles strength in patients with SIS, it will be conducted at the out-patient clinic of physical therapy in Pharos University in Alexandria, Egypt

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Double-blinded randomized controlled trial (patient and research assistant (the examiner of all patients) will be blinded).

Participants:

Thirty-four patients of both genders will be selected through non-probability sampling diagnosed as Neer's stage II SIS and their age range from 25-45 years will be randomly assigned to 1 of 2 groups. Each patient will sign an informed consent before starting the study (Appendix III).

Eligible patients will be recruited by physical therapist via referral from the treating orthopedic surgeon who will diagnose SIS based on clinical and radiological examination.

Group I (control): it includes 17 patients who will receive traditional strength training program.

Group II (experimental): it includes 17 patients who will receive upper extremity neuromuscular training exercises

Study Type

Interventional

Enrollment (Anticipated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient age from 25-40 with a clinical diagnosis of Neer's stage II SIS (Consigliere et al., 2018).

Shoulder pain for at least three months (Heron et al., 2017) Painful arc of movement during flexion or abduction (Heron et al., 2017). Positive Neer's or Kennedy- Hawkins Test (Heron et al., 2017). Pain on resisted external rotation, abduction or Empty Can Test (Ager et al., 2019).

Exclusion Criteria:

Symptoms of cervical radiculopathy. Diagnosed inflammatory disorder. Neurological disorder. Widespread pain condition. Evidence of complete RC tear (positive drop arm test). Previous surgery to the affected shoulder.

:

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group I (control)
: it includes 17 patients who will receive traditional strength training program.
traditional strength training exercises in group I
Experimental: Group II (experimental):
it includes 17 patients who will receive upper extremity neuromuscular training exercises
patients will receive neuromuscular training exercises in group II

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SPADI (The Shoulder Pain and Disability Index)
Time Frame: 6 weeks
It is a self-report questionnaire for shoulder function
6 weeks
Inclinometer
Time Frame: 6 weeks
joint position sense
6 weeks
Hand held dynamometer
Time Frame: 6 weeks
isometric muscle strength
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 20, 2021

Primary Completion (Anticipated)

October 1, 2022

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

September 1, 2021

First Submitted That Met QC Criteria

September 1, 2021

First Posted (Actual)

September 9, 2021

Study Record Updates

Last Update Posted (Actual)

December 16, 2021

Last Update Submitted That Met QC Criteria

December 15, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • shoulder neuromuscular

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on traditional training exerises

3
Subscribe